Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Vital Therapies logo

About Vital Therapies Stock (NASDAQ:VTL)

Advanced Chart

Key Stats

Today's Range
$1.11
$1.22
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
2.16 million shs
Average Volume
21.62 million shs
Market Capitalization
$48.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

VTL Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Lighthouse Center for Vital Living celebrates new building
Vardhman Textiles Ltd.
See More Headlines

VTL Stock Analysis - Frequently Asked Questions

Vital Therapies, Inc. (NASDAQ:VTL) announced its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.03.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vital Therapies investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Endologix (ELGX), Anthera Pharmaceuticals (ANTH), Bristol-Myers Squibb (BMY), Novavax (NVAX) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/07/2018
Today
5/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-41,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
3.97

Miscellaneous

Free Float
N/A
Market Cap
$48.73 million
Optionable
Not Optionable
Beta
3.51
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:VTL) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners